Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
55,868,344
-
Total 13F shares
-
8,959,139
-
Share change
-
-397,711
-
Total reported value
-
$35,236,264
-
Price per share
-
$3.93
-
Number of holders
-
57
-
Value change
-
-$1,727,005
-
Number of buys
-
21
-
Number of sells
-
21
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, par value $0.001 per share (VYGR) as of Q4 2025
As of 31 Dec 2025,
Voyager Therapeutics, Inc. - Common Stock, par value $0.001 per share (VYGR) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,959,139 shares.
The largest 10 holders included
VANGUARD GROUP INC, Erste Asset Management GmbH, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, JPMORGAN CHASE & CO, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Bank of New York Mellon Corp, and Patriot Financial Group Insurance Agency, LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.